跳至主要内容
临床试验/ACTRN12623000244606
ACTRN12623000244606尚未招募未知

Exploring the safety and feasibility of functional connectivity neurofeedback training for treatment of fibromyalgia- A pilot double blinded randomised placebo-controlled study.

niversity of Otago0 个研究点目标入组 30 人开始时间: 2023年3月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Participants with a diagnosis of fibromyalgia will be eligible to participate.
  • To be included in the study, participants must meet all of the following inclusion criteria:
  • Capable of understanding and signing an informed consent form
  • Age between 18 to 75 years on the day of the consent
  • Satisfy the Modified American Collage of Rheumatology (ACR) 2011 Fibromyalgia Diagnostic Criteria
  • A score greater than or equal to 4 on the 11-point numeric pain rating scale (NPRS, 0=No pain to 10=Worst pain) in the past 7 days
  • A disability score of greater than or equal to 50 on Fibromyalgia Impact Questionnaire

排除标准

  • Participants who meet any of the following conditions will be excluded:
  • Neurological conditions
  • Cognitive and psychiatric disorders
  • Substance abuse
  • Pregnant or six-months post-partum

研究者

相似试验

eurofeedback for Fibromyalgia. | 临床试验